(Q48629521)

13 February 2018

title

Efficacy of enzyme replacement therapy in an aggravated mouse model of metachromatic leukodystrophy declines with age. (English)

1 reference

13 February 2018

enzyme replacement therapy

main subject

0 references

metachromatic leukodystrophy

1 reference

Frank Matthes

1

1 reference

13 February 2018

Stijn Stroobants

2

1 reference

13 February 2018

Debora Gerlach

3

1 reference

13 February 2018

Claudia Wohlenberg

4

1 reference

13 February 2018

Carsten Wessig

5

1 reference

13 February 2018

Jens Fogh

6

1 reference

13 February 2018

Volkmar Gieselmann

7

1 reference

13 February 2018

Matthias Eckhardt

8

1 reference

13 February 2018

Rudi D'Hooge

9

1 reference

13 February 2018

Ulrich Matzner

10

1 reference

13 February 2018

publication date

2 March 2012

1 reference

13 February 2018

published in

Human Molecular Genetics

1 reference

13 February 2018

volume

21

1 reference

13 February 2018

issue

11

1 reference

13 February 2018

page(s)

2599-2609

1 reference

13 February 2018

Metachromatic leukodystrophy--an update

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS086

Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS086

Enzyme replacement improves ataxic gait and central nervous system histopathology in a mouse model of metachromatic leukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS086

Transport of arylsulfatase A across the blood-brain barrier in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS086

Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS086

Enzyme replacement therapy for murine mucopolysaccharidosis type VII

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS086

Enzyme replacement in murine mucopolysaccharidosis type VII: neuronal and glial response to beta-glucuronidase requires early initiation of enzyme replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS086

Enzyme-replacement therapy from birth delays the development of behavior and learning problems in mucopolysaccharidosis type IIIA mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS086

Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS086

Mannose 6-phosphate receptor-mediated transport of sulfamidase across the blood-brain barrier in the newborn mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS086

Early initiation of enzyme replacement therapy improves metabolic correction in the brain tissue of aspartylglycosaminuria mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS086

Enhancement of drug delivery: enzyme-replacement therapy for murine Morquio A syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS086

Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS086

Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS086

Induction of tolerance to human arylsulfatase A in a mouse model of metachromatic leukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS086

Differential staining of acid glycosaminoglycans (mucopolysaccharides) by alcian blue in salt solutions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS086

Lysosomal sulfatide storage in the brain of arylsulfatase A-deficient mice: cellular alterations and topographic distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS086

Early signs of neurolipidosis-related behavioural alterations in a murine model of metachromatic leukodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS086

Non-inhibitory antibodies impede lysosomal storage reduction during enzyme replacement therapy of a lysosomal storage disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS086

Lysosomal degradation of membrane lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS086

Development and reliability of a classification system for gross motor function in children with metachromatic leucodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS086

The natural course of gross motor deterioration in metachromatic leukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS086

Site-specific analysis of N-linked oligosaccharides of recombinant lysosomal arylsulfatase A produced in different cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS086

Axonal prion protein is required for peripheral myelin maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS086

21 January 2018

Identifiers

DOI

10.1093/HMG/DDS086

1 reference

13 February 2018

PubMed ID

22388935

1 reference

13 February 2018